Artificial Intelligence3 years ago
Harbour BioMed Reports 2021 Interim Results
Harbour BioMed (“HBM”, or the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, reported its...